The risk of pancreatic adenocarcinoma following SARS-CoV family infection
Abstract COVID 19 disease has become a global catastrophe over the past year that has claimed the lives of over two million people around the world. Despite the introduction of vaccines against the disease, there is still a long way to completely eradicate it. There are concerns about the complicati...
Guardado en:
Autores principales: | Amin Ebrahimi Sadrabadi, Ahmad Bereimipour, Arsalan Jalili, Mazaher Gholipurmalekabadi, Behrouz Farhadihosseinabadi, Alexander M. Seifalian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9bc72f639824761b1d31205d295689d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma
por: Cheng-Wei Chou, et al.
Publicado: (2021) -
Sweet Syndrome Following SARS-CoV2 Vaccination
por: Maria Efenesia Baffa, et al.
Publicado: (2021) -
Erythema Multiforme Major following SARS‐CoV‐2 vaccine
por: Alberto Maria Saibene, et al.
Publicado: (2021) -
Physician requirements for adoption of telehealth following the SARS-CoV-2 pandemic
por: Michael Hodgkins, et al.
Publicado: (2021) -
Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Eric M. Anderson, et al.
Publicado: (2021)